159 related articles for article (PubMed ID: 37154818)
21. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
23. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification.
Jiang L; Yan L; Wen T; Li B; Zeng Y; Yang J; Wang W; Xu M; Wu H
J Am Coll Surg; 2015 Nov; 221(5):951-61. PubMed ID: 26362135
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients.
Kao WY; Chao Y; Chang CC; Li CP; Su CW; Huo TI; Huang YH; Chang YJ; Lin HC; Wu JC
Medicine (Baltimore); 2015 Oct; 94(43):e1929. PubMed ID: 26512620
[TBL] [Abstract][Full Text] [Related]
26. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
[TBL] [Abstract][Full Text] [Related]
27. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
29. Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma.
Nouso K; Kariyama K; Nakamura S; Oonishi A; Wakuta A; Oyama A; Ako S; Dohi C; Wada N; Morimoto Y; Takeuchi Y; Kuwaki K; Onishi H; Ikeda F; Shiraha H; Takaki A; Okada H
J Gastroenterol Hepatol; 2017 Mar; 32(3):695-700. PubMed ID: 27597181
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492
[TBL] [Abstract][Full Text] [Related]
31. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
Hara K; Takeda A; Tsurugai Y; Saigusa Y; Sanuki N; Eriguchi T; Maeda S; Tanaka K; Numata K
Hepatology; 2019 Jun; 69(6):2533-2545. PubMed ID: 30805950
[TBL] [Abstract][Full Text] [Related]
34. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study.
Hsiao CY; Hu RH; Ho CM; Wu YM; Lee PH; Ho MC
Am J Surg; 2020 Oct; 220(4):958-964. PubMed ID: 32247523
[TBL] [Abstract][Full Text] [Related]
35. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma.
Lee J; Jin YJ; Shin SK; Kwon JH; Kim SG; Suh YJ; Jeong Y; Yu JH; Lee JW; Kwon OS; Nahm SW; Kim YS
Clin Mol Hepatol; 2022 Apr; 28(2):207-218. PubMed ID: 34814239
[TBL] [Abstract][Full Text] [Related]
36. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
[TBL] [Abstract][Full Text] [Related]
37. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
38. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
39. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
40. Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation.
Hu Z; Zeng H; Hou J; Wang J; Xu L; Zhang Y; Chen M; Zhou Z
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
